Marco Alifano

28PUBLICATIONS
118CO-AUTHORS
Predictive and prognostic markersCancer diagnosisBehavioural epidemiologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|May 26, 2026
Will We Need a Novel Heuristic in Resectable Lung Cancer?: A Narrative Review.

|Apr 17, 2026
Clustering by patients-related characteristics identifies specific phenotypes with different prognosis after resection of non-small cell lung cancer: a French nationwide study from the Epithor database.

|Feb 27, 2026
Validation of the 9th Edition of the TNM Classification in Patients with NSCLC and Lymph Node Involvement: A Retrospective, Multicentric, Observational Study.

Carolina Sassorossi, Marco Chiappetta, Filippo Lococo

|Aug 19, 2025
Beyond Body Mass Index: The Impact of Height and Height-Normalised Weight on Overall Survival of Lung Cancer Undergoing Surgery.

Lorenzo Gherzi, Mathilde Prieto, Antonio Iannelli

|Aug 05, 2025
Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.

Simon Baldacci, Elliott J Brea, Francesco Facchinetti

|Oct 21, 2024
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.

Gary Birsen, Valérie Gounant, Nicolas Girard

Pageof 5

Frequent Collaborators

3 joint publications

Marie Wislez

3 joint publications

Lorenzo Gherzi

3 joint publications

Ludovic Fournel

2 joint publications

Camille Tlemsani